| 1 |
Over-The-Counter Remedies in Older Adults |
|
|
| Delavar Safari, Elisabeth C. DeMarco, Lillian Scanlon, George T. Grossberg |
|
| Clinics in Geriatric Medicine. 2022; 38(1): 99 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
C-Kit, a Double-Edged Sword in Liver Regeneration and Diseases |
|
|
| Weina Wang, Liyan Shui, Yanning Liu, Min Zheng |
|
| Frontiers in Genetics. 2021; 12 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
Antinociceptive Effects of Sinomenine Combined With Ligustrazine or Paracetamol in Animal Models of Incisional and Inflammatory Pain |
|
|
| Tianle Gao, Tao Li, Wei Jiang, Weiming Fan, Xiao-Jun Xu, Xiaoliang Zhao, Zhenming Yin, Huihui Guo, Lulu Wang, Jun Gao, Yanxing Han, Jian-Dong Jiang, Danqiao Wang |
|
| Frontiers in Physiology. 2021; 11 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
RIPK2 Dictates Insulin Responses to Tyrosine Kinase Inhibitors in Obese Male Mice |
|
|
| Brittany M Duggan, Joseph F Cavallari, Kevin P Foley, Nicole G Barra, Jonathan D Schertzer |
|
| Endocrinology. 2020; 161(8) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Reviews on the Hepatotoxicity of Tyrosine Kinase Inhibitors |
|
|
| Ji Min Han, Hye Sun Gwak |
|
| Korean Journal of Clinical Pharmacy. 2019; 29(4): 223 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
Diclofenac sex-divergent drug-drug interaction with Sunitinib: pharmacokinetics and tissue distribution in male and female mice |
|
|
| Chii Chii Chew, Salby Ng, Yun Lee Chee, Teng Wai Koo, Ming Hui Liew, Evelyn Li-Ching Chee, Pilar Modamio, Cecilia Fernández, Eduardo L. Mariño, Ignacio Segarra |
|
| Investigational New Drugs. 2017; 35(4): 399 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 7 |
Sunitinib tissue distribution changes after coadministration with ketoconazole in mice |
|
|
| Evelyn Li-Ching Chee,Adeline Yi Ling Lim,Pilar Modamio,Cecilia Fernandez-Lastra,Ignacio Segarra |
|
| European Journal of Drug Metabolism and Pharmacokinetics. 2015; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 8 |
The effect of sunitinib on the plasma exposure of intravenous paracetamol and its major metabolite: paracetamol glucuronide |
|
|
| Agnieszka Karbownik,Edyta Szalek,Katarzyna Sobanska,Wojciech Polom,Tomasz Grabowski,Anna Biczysko-Murawa,Marcin Matuszewski,Anna Wolc,Edmund Grzeskowiak |
|
| European Journal of Drug Metabolism and Pharmacokinetics. 2014; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 9 |
Artemisia pallensalleviates acetaminophen induced toxicity via modulation of endogenous biomarkers |
|
|
| Varsha Honmore,Amit Kandhare,Anand A. Zanwar,Supada Rojatkar,Subhash Bodhankar,Arun Natu |
|
| Pharmaceutical Biology. 2014; : 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 10 |
Differential effects of ketoconazole, itraconazole and voriconazole on the pharmacokinetics of imatinib and its main metabolite GCP74588 in rat |
|
|
| Gaotong Lin,Chenming Wang,Xiangjun Qiu,Zhe Wang,Anyue Han,Tao Xu,Xin Kan,Guoxin Hu |
|
| Drug Development and Industrial Pharmacy. 2013; : 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 11 |
Hesperidin alleviates acetaminophen induced toxicity in wistar rats by abrogation of oxidative stress, apoptosis and inflammation |
|
|
| Shiekh Tanveer Ahmad, Wani Arjumand, Sana Nafees, Amlesh Seth, Nemat Ali, Summya Rashid, Sarwat Sultana |
|
| Toxicology Letters. 2011; |
|
| [HTML Full text] [Google Scholar] [DOI] |
|
| 12 |
Metronidazole leads to enhanced uptake of imatinib in brain, liver and kidney without affecting its plasma pharmacokinetics in mice : Imatinib - metronidazole interaction |
|
|
| Shin Yee Tan, Elaine Kan, Wei Yin Lim, Grace Chay, Jason H. K. Law, Gian Wan Soo, Nadeem Irfan Bukhari, Ignacio Segarra |
|
| Journal of Pharmacy and Pharmacology. 2011; : no |
|
| [HTML Full text] [Google Scholar] [DOI] |
|
| 13 |
Targeting the multidrug ABCG2 transporter with flavonoidic inhibitors: In Vitro optimization and in vivo validation |
|
|
| Boumendjel, A., MacAlou, S., Valdameri, G., Pozza, A., Gauthier, C., Arnaud, O., Nicolle, E., (...), Di Pietro, A. |
|
| Current Medicinal Chemistry. 2011; 18(22): 3387-3401 |
|
| [Pubmed] [Google Scholar] |
|
| 14 |
Association of genetic polymorphisms in the influx transporter SLCO1B3 and the efflux transporter ABCB1 with imatinib pharmacokinetics in patients with chronic myeloid leukemia |
|
|
| Yamakawa, Y., Hamada, A., Nakashima, R., Yuki, M., Hirayama, C., Kawaguchi, T., Saito, H. |
|
| Therapeutic Drug Monitoring. 2011; 33(2): 244-250 |
|
| [Pubmed] [Google Scholar] |
|
| 15 |
Histopathology and biochemistry analysis of the interaction between sunitinib and paracetamol in mice |
|
|
| Lim, A.Y.L., Segarra, I., Chakravarthi, S., Akram, S., Judson, J.P. |
|
| BMC Pharmacology. 2010; 10(art 10) |
|
| [Pubmed] [Google Scholar] |
|
| 16 |
Differential effects of ketoconazole and primaquine on the pharmacokinetics and tissue distribution of imatinib in mice |
|
|
| Soo, G.W., Law, J.H.K., Kan, E., Tan, S.Y., Lim, W.Y., Chay, G., Bukhari, N.I., Segarra, I. |
|
| Anti-Cancer Drugs. 2010; 21(7): 695-703 |
|
| [Pubmed] [Google Scholar] |
|
| 17 |
Disposition and tissue distribution of imatinib in a liposome formulation after intravenous bolus dose to mice |
|
|
| Moo, K.S., Radhakrishnan, S., Teoh, M., Narayanan, P., Bukhari, N.I., Segarra, I. |
|
| Yaoxue Xuebao. 2010; 45(7): 901-908 |
|
| [Pubmed] [Google Scholar] |
|
| 18 |
Histopathological study of the hepatic and renal toxicity associated with the co-administration of imatinib and acetaminophen in a preclinical mouse model |
|
|
| Nassar, I., Pasupati, T., Judson, J.P., Segarra, I. |
|
| Malaysian Journal of Pathology. 2010; 32(1): 1-11 |
|
| [Pubmed] [Google Scholar] |
|
| 19 |
Histopathology and biochemistry analysis of the interaction between sunitinib and paracetamol in mice |
|
|
| Adeline YL Lim, Ignacio Segarra, Srikumar Chakravarthi, Sufyan Akram, John P Judson |
|
| BMC Pharmacology. 2010; 10(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 20 |
Differential effects of ketoconazole and primaquine on the pharmacokinetics and tissue distribution of imatinib in mice |
|
|
| Gian Wan Soo, Jason H.K. Law, Elaine Kan, Shin Yee Tan, Wei Yin Lim, Grace Chay, Nadeem I. Bukhari, Ignacio Segarra |
|
| Anti-Cancer Drugs. 2010; 21(7): 695 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
